Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 35% ± 14% | |
peripheral blood | 13 studies | 42% ± 21% | |
intestine | 10 studies | 36% ± 17% | |
kidney | 7 studies | 41% ± 18% | |
brain | 6 studies | 26% ± 9% | |
lymph node | 5 studies | 47% ± 22% | |
eye | 4 studies | 39% ± 30% | |
uterus | 4 studies | 70% ± 11% | |
breast | 4 studies | 49% ± 20% | |
liver | 4 studies | 50% ± 24% | |
placenta | 3 studies | 81% ± 9% | |
bone marrow | 3 studies | 36% ± 22% | |
prostate | 3 studies | 74% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 29001.17 | 1444 / 1445 | 93% | 3.19 | 170 / 183 |
lung | 100% | 33454.46 | 578 / 578 | 77% | 2.30 | 887 / 1155 |
stomach | 100% | 21755.99 | 359 / 359 | 73% | 1.76 | 210 / 286 |
bladder | 100% | 28204.24 | 21 / 21 | 71% | 1.77 | 359 / 504 |
intestine | 100% | 22123.05 | 966 / 966 | 71% | 1.76 | 375 / 527 |
pancreas | 98% | 17655.18 | 323 / 328 | 72% | 1.78 | 128 / 178 |
uterus | 100% | 23714.06 | 170 / 170 | 66% | 1.55 | 301 / 459 |
ovary | 100% | 28368.56 | 180 / 180 | 64% | 1.65 | 276 / 430 |
skin | 100% | 42657.12 | 1809 / 1809 | 62% | 1.51 | 291 / 472 |
prostate | 100% | 22337.48 | 245 / 245 | 58% | 1.21 | 289 / 502 |
brain | 91% | 8604.27 | 2412 / 2642 | 64% | 1.46 | 450 / 705 |
kidney | 100% | 19522.88 | 89 / 89 | 53% | 1.65 | 474 / 901 |
breast | 100% | 33126.20 | 459 / 459 | 45% | 0.92 | 503 / 1118 |
adrenal gland | 100% | 30561.48 | 258 / 258 | 36% | 0.69 | 83 / 230 |
thymus | 100% | 18468.08 | 652 / 653 | 36% | 0.67 | 219 / 605 |
liver | 100% | 15786.76 | 225 / 226 | 18% | 0.34 | 73 / 406 |
adipose | 100% | 38397.71 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 27527.76 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 23561.39 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 27335.76 | 919 / 929 | 0% | 0 | 0 / 0 |
heart | 95% | 13378.89 | 820 / 861 | 0% | 0 | 0 / 0 |
muscle | 89% | 13058.46 | 714 / 803 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.39 | 16 / 29 |
tonsil | 0% | 0 | 0 / 0 | 53% | 0.97 | 24 / 45 |
eye | 0% | 0 | 0 / 0 | 36% | 0.80 | 29 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002183 | Biological process | cytoplasmic translational initiation |
GO_0006413 | Biological process | translational initiation |
GO_0016020 | Cellular component | membrane |
GO_0070062 | Cellular component | extracellular exosome |
GO_0016281 | Cellular component | eukaryotic translation initiation factor 4F complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0000339 | Molecular function | RNA cap binding |
GO_0008135 | Molecular function | translation factor activity, RNA binding |
GO_0004386 | Molecular function | helicase activity |
GO_0003724 | Molecular function | RNA helicase activity |
GO_0003743 | Molecular function | translation initiation factor activity |
GO_0003729 | Molecular function | mRNA binding |
GO_0005524 | Molecular function | ATP binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
GO_0016887 | Molecular function | ATP hydrolysis activity |
GO_0003725 | Molecular function | double-stranded RNA binding |
Gene name | EIF4A1 |
Protein name | Eukaryotic initiation factor 4AI Eukaryotic translation initiation factor 4A1 RNA helicase (EC 3.6.4.13) Eukaryotic initiation factor 4A-I (eIF-4A-I) (eIF4A-I) (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1) Eukaryotic initiation factor 4A-I (EC 3.6.4.13) (ATP-dependent RNA helicase eIF4A-1) |
Synonyms | DDX2A EIF4A |
Description | FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . FUNCTION: ATP-dependent RNA helicase which is a subunit of the eIF4F complex involved in cap recognition and is required for mRNA binding to ribosome. In the current model of translation initiation, eIF4A unwinds RNA secondary structures in the 5'-UTR of mRNAs which is necessary to allow efficient binding of the small ribosomal subunit, and subsequent scanning for the initiator codon. . |
Accessions | J3KT12 ENST00000583802.5 J3KS93 J3QQP0 J3QL43 ENST00000578476.5 J3QLN6 ENST00000584784.5 J3QL52 J3QRP5 J3QS69 J3QKZ9 ENST00000578495.5 ENST00000581384.5 J3KRC2 ENST00000580461.5 ENST00000581544.5 ENST00000585024.5 ENST00000583389.5 ENST00000579139.1 J3KS25 ENST00000582169.5 P60842 J3QR64 J3KSZ0 ENST00000578754.5 ENST00000582050.1 ENST00000582746.5 Q9NZR9 ENST00000577269.5 [P60842-2] ENST00000293831.13 [P60842-1] ENST00000577929.1 J3KTN0 |